Section Arrow
DNLI.NASDAQ
- Denali Therapeutics
Quotes are at least 15-min delayed:2026/01/09 07:37 EST
Pre Market
Last
 17.33
+0.26 (+1.52%)
Bid
16.74
Ask
18.73
High 17.33 
Low 17.07 
Volume 117 
Regular Hours (Closed)
Last
 17.07
+0.12 (+0.71%)
Day High 
17.57 
Prev. Close
16.95 
1-M High
20.567 
Volume 
1.76M 
Bid
16.74
Ask
18.73
Day Low
16.64 
Open
16.98 
1-M Low
15.34 
Market Cap 
2.65B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 16.66 
20-SMA 17.07 
50-SMA 17.24 
52-W High 24.345 
52-W Low 10.57 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.92/-2.17
Enterprise Value
2.68B
Balance Sheet
Book Value Per Share
5.93
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
2.18
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1033-0.0223-17.75%-- 
Pre Market 0.1003 -0.003 -2.90%
ACRVAcrivon Therapeutics1.93-1.02-34.58%-- 
Pre Market 1.89 -0.04 -2.07%
VTYXVentyx Biosciences13.84+0.11+0.80%-- 
Pre Market 13.81 -0.03 -0.22%
MLTXMoonLake Immunotherapeutics14.34+3.05+27.02%-- 
Pre Market 15.11 +0.77 +5.37%
CRMDCorMedix7.51-3.66-32.77%5.05PE
Pre Market 7.55 +0.04 +0.53%
Industry overview quotes are at least 15 minutes delayed
Business Description
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brainpenetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.